,
4 tweets,
1 min read
Read on Twitter
This is grotesque.
“the US is a global outlier on money spent on the drug, representing only 15 percent of the global insulin market and generating almost half of the pharmaceutical industry’s insulin revenue.”
The problem with market solutions to health care prices is consumers can’t say no. You either get the insulin or you die.
Other countries solve this by having the government negotiate the price. Then it’s the drug company that can’t say no. You either sell at a reasonable price, or you lose the entire market.
